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The cytokine transforming growth factor-b (TGF-b) is an important negative regulator of adaptive immunity [1] [2] [3] . TGF-b is secreted by cells as an inactive precursor that must be activated to exert biological effects 4 , but the mechanisms that regulate TGF-b activation and function in the immune system are poorly understood. Here we show that conditional loss of the TGF-b-activating integrin a v b 8 on leukocytes causes severe inflammatory bowel disease and age-related autoimmunity in mice. This autoimmune phenotype is largely due to lack of a v b 8 The critical pathways for activation of latent TGF-b at specific sites in vivo remain controversial. One important mechanism for activation of two of the three mammalian TGF-b isoforms (TGF-b1 and TGF-b3) is through interaction with members of the integrin receptor family [5] [6] [7] . The in vivo importance of TGF-b activation by integrins has been recently demonstrated in mice with a mutated integrinbinding motif in TGF-b1 (ref. 8) . These mice completely phenocopy Tgfb1 2/2 mice, which die from multi-organ inflammatory disease 1 , showing that integrin-mediated TGF-b activation is vital to maintain immune homeostasis. However, the integrin(s) responsible for TGFb activation in the immune system in vivo, where these integrins are expressed, and the mechanisms by which integrin-mediated TGF-b activation maintains immune homeostasis remain a mystery.
The integrin a v b 6 has previously been shown to activate TGF-b (ref. 6) , but this integrin is restricted to a subset of epithelial cells and is not expressed on immune cells. Furthermore, the inflammatory phenotype of mice lacking a v b 6 is mild compared to mice lacking TGF-b1 or TGF-b3 (ref. 5). The a v b 8 integrin can also activate TGF-b (ref. 7) . Mice completely lacking a v b 8 die before or shortly after birth from defects in brain vascular development 9 , so tissue-specific deletion was required to determine whether a v b 8 -mediated TGF-b activation has a function in regulating adaptive immunity. Polymerase chain reaction with reverse transcription (RT-PCR) analysis revealed that b 8 was expressed in total splenocytes, CD4
1 T cells and dendritic cells (Supplementary Fig. 1a) Fig. 1b ).
fl/fl mice were phenotypically normal until 4-5 months of age, when they began to develop a progressive wasting disorder (Fig. 1a) . (Vav1-cre)Itgb8 fl/fl mice also developed splenomegaly, massive enlargement of mesenteric lymph nodes (Fig. 1b) and accumulations of mononuclear cells adjacent to portal triads of the liver (Fig. 1c) . By 10 months of age, all surviving (Vav1-cre)Itgb8 fl/fl mice developed severe colitis, characterized by cellular infiltration of the colonic wall with eosinophils and plasma cells, and formation of colonic cysts (Fig. 1d) . These mice also developed high levels of auto-antibodies directed against double-stranded DNA and ribonuclear proteins (Fig. 1e ). These findings are remarkably similar to phenotypes described for mice with a partial loss of TGF-b signalling in T cells as a result of expression of a dominant negative TGF-b receptor 12 , and for mice lacking the key TGF-b signalling protein Smad4 in T cells 13 . Mice lacking Smad4 in T cells also had increased tumorigenesis 13 , a finding we did not observe. PCR of stool samples revealed the presence of the common intestinal bacteria Helicobacter hepaticus and Helicobacter ganmani from all control and experimental mice tested. These organisms, endemic in our facility and in over 85% of mouse research colonies worldwide 14, 15 , are not pathogenic in most strains of mice, but have been reported to cause colitis and hepatic inflammation in some immunosuppressed strains 16 . We therefore cannot exclude the possibility that the presence of these organisms, or other unmeasured microbial flora, contribute to the severity of colonic and/or hepatic pathology in (Vav1-cre)Itgb8 fl/fl mice. Such a response could be relevant to inflammatory bowel diseases in humans, where abnormal responses to normally non-pathogenic intestinal flora have been suggested to have a role 17 . Mice with impaired T-cell responsiveness to TGF-b were also shown to have increased numbers of activated peripheral T cells, increased circulating levels of IgA and IgG1, and increased numbers of T cells that produce interleukin-4 (IL-4) and/or interferon-c (IFNc) 12 . (Vav1-cre)Itgb8 fl/fl mice (4-6 months old) also had enhanced numbers of activated/memory CD4 1 and CD8 1 T cells (Fig. 2a) , and increased numbers of CD4 1 T cells producing IFN-c and IL-4, and CD8
1 cells producing IFN-c ( Fig. 2b and Supplementary Fig. 2 ).
(Vav1-cre)Itgb8 fl/fl mice also had increased levels of circulating IgE, IgG1 and IgA (Fig. 2c) , whereas levels of IgM, IgG2a, IgG2b and IgG3 were not significantly different ( Supplementary Fig. 3 ). Again, these features were virtually identical to those described in mice with a partial loss of TGF-b signalling in T cells, suggesting that a v b 8 on leukocytes has an important role in activating TGF-b for presentation to T cells. This phenotype is not due to the mixed genetic background analysed in these initial experiments, because mice bred five generations to pure C57BL/6 background have a similar immune phenotype and also develop colitis ( Supplementary Fig. 4 ).
We next assessed whether loss of a v b 8 on either dendritic cells or T cells was responsible for the in vivo phenotype observed in (Vav1-cre)Itgb8 fl/fl mice by crossing mice homozygous for the Itgb8-floxed allele with mice expressing Cre recombinase principally in T cells (CD4-Cre) 18 or dendritic cells (CD11c-Cre) 19 . By qRT-PCR we saw a greater than 99% reduction in Itgb8 mRNA levels in CD4
1 T cells from Itgb8 fl/fl mice expressing CD4-Cre ((CD4-cre)Itgb8 fl/fl ), with a modest reduction in dendritic cells ( Supplementary Fig. 5a ). Greater than 99% reduction in Itgb8 mRNA levels was found in dendritic cells from Itgb8 fl/fl mice expressing CD11c-Cre ((CD11c-cre)Itgb8 fl/fl ), with a modest reduction in CD4
1 T cells ( Supplementary Fig. 5b ).
Therefore, (CD4-cre)Itgb8 fl/fl mice completely lacked b 8 expression in CD4 1 T cells, but only partially in dendritic cells, whereas (CD11c-cre)Itgb8 fl/fl mice completely lacked b 8 expression in dendritic cells, but only partially in CD4 1 T cells. By 4-6 weeks of age, (Vav1-cre)Itgb8 fl/fl mice already had increased numbers of activated/memory T cells, increased T-cell production of IFN-c and/or IL-4, and increased circulating levels of IgE, IgG1 and IgA (Fig. 3) . In contrast, (CD4-cre)Itgb8 fl/fl mice were indistinguishable from control mice, and showed no signs of illness up to at least 14 months of age. (CD11c-cre)Itgb8 fl/fl mice show an identical immunological phenotype to mice lacking b 8 integrin on all leukocytes, with significantly increased numbers of activated/memory T cells (Fig. 3a) , increased T cells expressing IFN-c and/or IL-4 ( Fig. 3b) , and increases in serum IgE, IgG1 and IgA levels (Fig. 3c) . Older
with significant weight loss, enlarged spleen and mesenteric lymph nodes, infiltrates in portal triads of the liver, and development of colonic inflammation (Supplementary Fig. 6 ). These results suggest that expression of the a v b 8 integrin on dendritic cells is vital for the negative regulation of adaptive immunity. Loss of a v b 8 on T cells is not by itself sufficient to cause any aspects of this phenotype. However, because CD11c-Cre did cause a modest reduction in b 8 expression in CD4
1 T cells, we cannot exclude a minor contribution from partial loss of a v b 8 on these cells.
Mice lacking T R cells also develop severe autoimmunity 20 , and recent work has shown an important role for TGF-b in the biology of T R cells [21] [22] [23] [24] . We therefore examined the ability of control or b 8 -deficient dendritic cells to induce T R cells from CD4 1 T cells in an in vitro T-cell activation assay. Both control and b 8 -deficient dendritic cells showed similar populations of myeloid (CD11c   high   CD8 2 ), lymphoid (CD11c high CD8
) and plasmacytoid (CD11c low B220 1 ) dendritic cells ( Supplementary Fig. 7a) , with comparable expression of the activation markers CD86 and major histocompatibility complex (MHC) class II ( Supplementary Fig. 7b ), indicating that lack of b 8 integrin does not affect the development or maturation of dendritic cells. In the presence of control dendritic cells approximately 3% of CD4
1 T cells converted to T R cells (determined by expression of the T R -cell-specific reporter gene Foxp3-Gfp 25 ) and induction was inhibited by an anti-TGF-b antibody (Fig. 4a) . However, in the presence of b 8 -deficient dendritic cells, T R cell induction was markedly reduced (Fig. 4a) . Addition of active TGF-b to cultures containing either control or b 8 -deficient dendritic cells resulted in a similar induction of T R cells (Fig. 4b) . Co-culture with TGF-b-luciferase reporter cells also demonstrated decreased TGF-b activity generated by b 8 -deficient dendritic cells compared to control dendritic cells (Fig. 4c) .
To determine whether there was a defect in T R cell induction by b 8 -deficient dendritic cells in vivo, we analysed CD4
1 Foxp3 1 T R cells in the spleen or colon of young (8-14 weeks) control or (CD11c-cre)Itgb8 fl/fl mice. No difference in the proportion of T R cells was observed in the spleens, but there was a greater than 50% reduction in the proportion of T R cells recovered from the colonic lamina ). b, IL-4 and IFN-c levels in T cells from spleen were analysed by intracellular flow cytometry. Representative flow cytometry plots and plotted mean values are shown (white, control; black, Itgb8 conditional knockout; n 5 6 per group; asterisk, P , 0.0063; double asterisk, P 5 0.0055; triple asterisk, P 5 0.0045). c, ELISA for IgE, IgG1 and IgA levels in sera (4-6-week-old mice; white, control; black, Itgb8 conditional knockout; n 5 6; asterisk, P , 0.0018; double asterisk, P , 0.016; triple asterisk, P 5 0.0015). All error bars represent s.e.m. propria of (CD11c-cre)Itgb8 fl/fl mice (Fig. 4d) . We cannot rule out the possibility that CD4 1 effector cell expansion contributes to the observed reduction in the fractional number of T R cells in the colon. However, taken together, our in vitro and in vivo results suggest that activation of TGF-b by a v b 8 on dendritic cells is important for the induction of T R cells in peripheral tissues such as the colon, and that a defect in T R cell induction and/or maintenance could contribute to the autoimmunity and colitis in (CD11c-cre)Itgb8 fl/fl mice. Because the phenotype we observed is markedly similar to that of mice with impaired TGF-b signalling in T cells, and a v b 8 on dendritic cells activates TGF-b, our results suggest a key negative regulatory role for presentation of active TGF-b from a v b 8 on dendritic cells to T cells. Our findings further suggest that the aberrant immune homeostasis we observed may be explained by the known role of TGF-b in induction of Foxp3 expression 21 and resultant differentiation of T cells to T R cells. However, whereas T R cells in the colon were decreased in (CD11c-cre)Itgb8 fl/fl mice, numbers of T R cells in the spleen were normal. These results may be explained by a difference in the mechanisms underlying the generation of natural/innate T R cells that are the primary contributor to T R cells in the spleen, lymph nodes and circulation, and adaptive T R cells that are critical for maintaining peripheral homeostasis and preventing diseases such as colitis 26, 27 . In addition to T R cell abnormalities, the observed autoimmune phenotype could be partially explained by a role for dendritic cell a v b 8 -mediated TGF-b activation in the direct regulation of T-cell function, as it is known that TGF-b can also directly suppress effector T cells 28 . As described earlier, mutation of the RGD integrin-binding site in TGF-b1 results in a more severe autoimmune phenotype reminiscent of loss of TGF-b1 (ref. 8) . Therefore, it is likely that activation of TGF-b by other integrins or cell types is also important for the maintenance of immune homeostasis. For example, the a v b 6 integrin on epithelial cells or the a v b 8 integrin on resident tissue cells might also contribute to T R cell induction and immune suppression at specific sites. Notably, in the absence of the a v b 8 integrin on dendritic cells, mice demonstrate widespread evidence of immune activation, autoimmunity and colitis, suggesting that genetic or acquired abnormalities in a v b 8 might contribute to the development of inflammatory bowel disease or other autoimmune disorders.
METHODS SUMMARY
Mice. Mice expressing a floxed allele of Itgb8 have been described 10 , and were maintained on a mixed CD1, FVB and C57BL/6 background. Vav1-Cre mice were a gift from D. Kioussis 11 . CD4-Cre mice 18 were purchased from Taconic. For some experiments, alleles were bred for five generations to C57BL/6 mice. CD11c-Cre mouse generation is described in a separate manuscript 19 . Foxp3-GFP mice were a gift from A. Rudensky 25 . All mice were maintained under pathogen-free conditions, according to institutional guidelines. Cell purification and flow cytometry. Cells were purified using magnetic beads (Miltenyi) or by flow cytometry. Flow cytometry data analysis was performed using FloJo software (Treestar). Quantitative RT-PCR. RNA was isolated using an RNeasy mini kit (Qiagen), and reverse transcribed using Superscript II RT (Invitrogen). Quantitative PCR was performed using a Sybr Green qRT-PCR kit (Invitrogen). Primers used are detailed in the Methods. Cytokine production assays. Splenocytes (5 3 10 6 ml
21
) were incubated with 50 ng ml 21 PMA (Sigma) and 1 mM ionomycin (Calbiochem). For intracellular flow cytometry, cells were cultured for 2 h followed by addition of 2 mM monensin (eBioscience) and cultured for another 2 h. For ELISA analysis, cells were cultured for 24 h and supernatants harvested. Colon lamina propria cell preparation. Colonic lamina propria lymphocytes were isolated as described 29 , with slight modification (see Methods). Statistical analysis. All statistics were generated using a Student's t-test. All error bars in figures represent s.e.m.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature.
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